Sorrento Therapeutics Inc SRNE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:28 PM EDT
7.51quote price arrow up+0.02 (+0.27%)
Volume
4,673,837
52 week range
2.18 - 19.39

...

Loading . . .
  • Open7.41
  • Day High7.80
  • Day Low7.32
  • Prev Close7.49
  • 52 Week High19.39
  • 52 Week High Date08/10/20
  • 52 Week Low2.18
  • 52 Week Low Date05/01/20

Key Stats

  • Market Cap2.109B
  • Shares Out280.86M
  • 10 Day Average Volume8.61M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change9.34

KEY STATS

  • Open7.41
  • Day High7.80
  • Day Low7.32
  • Prev Close7.49
  • 52 Week High19.39
  • 52 Week High Date08/10/20
  • 52 Week Low2.18
  • 52 Week Low Date05/01/20
  • Market Cap2.109B
  • Shares Out280.86M
  • 10 Day Average Volume8.61M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change9.34

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-5.70
  • Fwd P/E (NTM)4.67
  • EBITDA (MRQ)-233.511M
  • ROE (MRQ)-244.90%
  • Revenue (MRQ)39.99M
  • Gross Margin (MRQ)75.14%
  • Net Margin (MRQ)-771.68%
  • Debt To Equity (MRQ)69.92%

EVENTS

  • Earnings Date05/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Sorrento Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Sorrento Therapeutics, Inc. is a clinical-stage and commercial biopharma company. The Company operates through two segments: Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next generation of cancer therapeutics. These modalities include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor...
Henry Ji Ph.D.
Chairman
Najjam Asghar
Chief Financial Officer
Address
4955 Directors Pl
San Diego, CA
92121-3836
United States

Top Peers

SYMBOLLASTCHG%CHG
MCRB
Seres Therapeutics Inc
19.90-0.83-4.00%
MORF
Morphic Holding Inc
54.60-0.47-0.86%
RVNC
Revance Therapeutics Inc
27.26+0.04+0.15%
BCRX
BioCryst Pharmaceuticals Inc
11.41+0.17+1.52%
CYTK
Cytokinetics Inc
24.84+0.14+0.57%